104 related articles for article (PubMed ID: 20673885)
1. Early activation does not translate into effector differentiation of peripheral CD8T cells during the acute phase of Kawasaki disease.
Ehara H; Kiyohara K; Izumisawa Y; Ito T
Cell Immunol; 2010; 265(1):57-64. PubMed ID: 20673885
[TBL] [Abstract][Full Text] [Related]
2. [Changes in CD69, CD25 and HLA-DR expressions in peripheral blood T cells in Kawasaki disease].
Zhang YY; Huang XM; Kang ML; Gong FQ; Qian BQ
Zhonghua Er Ke Za Zhi; 2006 May; 44(5):329-32. PubMed ID: 16780706
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease.
Ichiyama T; Ueno Y; Hasegawa M; Ishikawa Y; Matsubara T; Furukawa S
Rheumatology (Oxford); 2005 Mar; 44(3):314-7. PubMed ID: 15572393
[TBL] [Abstract][Full Text] [Related]
4. TCR V beta family repertoire and T cell activation markers in Kawasaki disease.
Pietra BA; De Inocencio J; Giannini EH; Hirsch R
J Immunol; 1994 Aug; 153(4):1881-8. PubMed ID: 7913945
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
Ye Q; Gong FQ; Shang SQ; Hu J
Clin Immunol; 2016 Oct; 171():25-31. PubMed ID: 27519954
[TBL] [Abstract][Full Text] [Related]
6. Clonal expansion of CD8+ T cells in Kawasaki disease.
Choi IH; Chwae YJ; Shim WS; Kim DS; Kwon DH; Kim JD; Kim SJ
J Immunol; 1997 Jul; 159(1):481-6. PubMed ID: 9200489
[TBL] [Abstract][Full Text] [Related]
7. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
Wakiguchi H; Hasegawa S; Suzuki Y; Kudo K; Ichiyama T
Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740
[TBL] [Abstract][Full Text] [Related]
8. Activation-associated phenotype of CD3 T cells in acute graft-versus-host disease.
Paz Morante M; Briones J; Canto E; Sabzevari H; Martino R; Sierra J; Rodriguez-Sanchez JL; Vidal S
Clin Exp Immunol; 2006 Jul; 145(1):36-43. PubMed ID: 16792671
[TBL] [Abstract][Full Text] [Related]
9. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
[TBL] [Abstract][Full Text] [Related]
10. [Expression of LFA-1 and ICAM-1 on peripheral blood T-cells and soluble CD2 levels in serum during acute Kawasaki disease].
Tsuji K
Arerugi; 1993 Apr; 42(4):564-70. PubMed ID: 8323454
[TBL] [Abstract][Full Text] [Related]
11. Analysis of T-cell receptor V-beta 2 in peripheral blood lymphocytes as a diagnostic marker for Kawasaki disease.
Reichardt P; Lehmann I; Sierig G; Borte M
Infection; 2002 Dec; 30(6):360-4. PubMed ID: 12478326
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease.
Ichiyama T; Yoshitomi T; Nishikawa M; Fujiwara M; Matsubara T; Hayashi T; Furukawa S
Clin Immunol; 2001 Jun; 99(3):373-7. PubMed ID: 11358434
[TBL] [Abstract][Full Text] [Related]
13. Levels of intra- and extracellular heat shock protein 60 in Kawasaki disease patients treated with intravenous immunoglobulin.
Yin Ji X; Kang MR; Choi JS; Jeon HS; Han HS; Kim JY; Son BR; Lee YM; Hahn YS
Clin Immunol; 2007 Sep; 124(3):304-10. PubMed ID: 17602873
[TBL] [Abstract][Full Text] [Related]
14. Activin a suppresses peripheral CD8
Wu Q; Weng R; Xu Y; Wang L; Huang Y; Yang J
BMC Immunol; 2021 Feb; 22(1):17. PubMed ID: 33622252
[TBL] [Abstract][Full Text] [Related]
15. [Serum interleukin-2 receptor in patients with Kawasaki disease].
Matsubara T
Arerugi; 1989 Jan; 38(1):49-56. PubMed ID: 2662945
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunologic aspects of Kawasaki disease.
Leung DY
Immunodefic Rev; 1989; 1(3):261-71. PubMed ID: 2698643
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical studies on small intestinal mucosa in Kawasaki disease.
Nagata S; Yamashiro Y; Maeda M; Ohtsuka Y; Yabuta K
Pediatr Res; 1993 Jun; 33(6):557-63. PubMed ID: 8378111
[TBL] [Abstract][Full Text] [Related]
18. Transient low T cell response to streptococcal pyrogenic exotoxin-C in patients with Kawasaki disease.
Masuda K; Takei S; Nomura Y; Imanaka H; Sameshima K; Yoshinaga M
Pediatr Res; 1998 Jul; 44(1):27-31. PubMed ID: 9667366
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease.
Matsuguma C; Wakiguchi H; Suzuki Y; Okada S; Furuta T; Ohnishi Y; Azuma Y; Ohga S; Hasegawa S
Scand J Rheumatol; 2019 Nov; 48(6):491-496. PubMed ID: 31272272
[No Abstract] [Full Text] [Related]
20. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
Czyz A; Kołacz E; Angerer D; Zawilska K
Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
